Discover

VCYT
Veracyte, Inc.
46.45
1 x 46.41
1 x 46.49
bid
ask
+
0.18
0.38%
02:54 PM
timesize
Ytd10.32%
1y65.94%
45.72
day range
46.67
27.79
52 week range
60.91
Open46.07Prev Close46.27Low45.72High46.67Mkt Cap3.71B
Vol312.52KAvg Vol1.32MEPS2.00P/E23.23Forward P/E24.24
Beta1.95Short Ratio4.77Inst. Own112.09%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning07-3050-d Avg53.41200-d Avg42.211yr Est57.82

VCYT News

Veracyte: Diagnostics With Favorable Economics
seekingalpha.com
Veracyte: Diagnostics With Favorable Economics

Veracyte's core tests are Decipher and Afirma. Both of these tests are producing double-digit growth

Veracyte: Core Growth Funds Prosigna And TrueMRD
seekingalpha.com
Veracyte: Core Growth Funds Prosigna And TrueMRD

Veracyte (VCYT) is evolving into a self-funded cancer diagnostic platform, leveraging clinical evide

Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
benzinga.com
Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. stock futures rise, Nasdaq 100 up 300 points. Apple Inc shares fall 7.4% despite beating analys

Veracyte, Inc. (VCYT) Q2 2026 Earnings Call Transcript
seekingalpha.com
Veracyte, Inc. (VCYT) Q2 2026 Earnings Call Transcript

Veracyte, Inc. (VCYT) Q2 2026 Earnings Call Transcript

Veracyte (VCYT) Q2 Earnings and Revenues Surpass Estimates
zacks.com
Veracyte (VCYT) Q2 Earnings and Revenues Surpass Estimates

Veracyte (VCYT) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Est

Veracyte Announces Second Quarter 2026 Financial Results
globenewswire.com
Veracyte Announces Second Quarter 2026 Financial Results

Grew total revenue to  $150.3 million and testing revenue to $145.7 million , representing increases

Veracyte to Participate in Upcoming Investor Conferences
globenewswire.com
Veracyte to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Veracyte, Inc. (Nasdaq: VCYT), a lead

First Trust Advisors LP Buys 833,543 Shares of Veracyte, Inc. $VCYT
defenseworld.net
First Trust Advisors LP Buys 833,543 Shares of Veracyte, Inc. $VCYT

First Trust Advisors LP lifted its stake in shares of Veracyte, Inc. (NASDAQ: VCYT) by 64.9% in the

Earnings Preview: Veracyte (VCYT) Q2 Earnings Expected to Decline
zacks.com
Earnings Preview: Veracyte (VCYT) Q2 Earnings Expected to Decline

Veracyte (VCYT) doesn't possess the right combination of the two key ingredients for a likely earnin

Which Is the Better Healthcare ETF: First Trust's High-Conviction FBT or Vanguard's Low-Cost VHT?
fool.com
Which Is the Better Healthcare ETF: First Trust's High-Conviction FBT or Vanguard's Low-Cost VHT?

FBT surged 51.6% in one year but carries higher risk and costs. VHT offers broader diversification a

Fifth Third Bancorp Purchases 52,043 Shares of Veracyte, Inc. $VCYT
defenseworld.net
Fifth Third Bancorp Purchases 52,043 Shares of Veracyte, Inc. $VCYT

Fifth Third Bancorp boosted its position in shares of Veracyte, Inc. (NASDAQ: VCYT) by 10,285.2% dur

Which Is the Better Healthcare ETF, First Trust's Biotech-Focused FBT or State Street's Broader XLV?
fool.com
Which Is the Better Healthcare ETF, First Trust's Biotech-Focused FBT or State Street's Broader XLV?

FBT delivered 52.4% returns over one year but with deeper drawdowns, while XLV's diversified approac

Amova Asset Management Americas Inc. Has $33.63 Million Holdings in Veracyte, Inc. $VCYT
defenseworld.net
Amova Asset Management Americas Inc. Has $33.63 Million Holdings in Veracyte, Inc. $VCYT

Amova Asset Management Americas Inc. lessened its stake in shares of Veracyte, Inc. (NASDAQ: VCYT) b

Artisan Mid Cap Fund Q2 2026 Performance Review
seekingalpha.com
Artisan Mid Cap Fund Q2 2026 Performance Review

Artisan Mid Cap Fund portfolio generated strong absolute returns and outpaced the Russell Midcap® Gr

This Veracyte Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
benzinga.com
This Veracyte Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

This Veracyte Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
benzinga.com
This Veracyte Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Wall Street analysts initiated coverage on various top stocks, including VCYT, UMAC, FISN, LTRX, and

benzinga.com
Piper Sandler Initiates Coverage On Veracyte with Overweight Rating, Announces Price Target of $66

Piper Sandler analyst David Westenberg initiates coverage on Veracyte (NASDAQ:VCYT) with a Overwe

benzinga.com
Canaccord Genuity Maintains Hold on Veracyte, Raises Price Target to $60

Canaccord Genuity analyst Kyle Mikson maintains Veracyte (NASDAQ:VCYT) with a Hold and raises the

Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026
businesswire.com
Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagno

All You Need to Know About Veracyte (VCYT) Rating Upgrade to Strong Buy
zacks.com
All You Need to Know About Veracyte (VCYT) Rating Upgrade to Strong Buy

Veracyte (VCYT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about

A Veracyte Insider Sold 24,000 Company Shares for $1.1 Million. Here's a Deeper Look at the Transaction.
fool.com
A Veracyte Insider Sold 24,000 Company Shares for $1.1 Million. Here's a Deeper Look at the Transact

Chief Accounting Officer Jonathan Wygant sold 24,000 shares on May 22, 2026, generating a transactio

Veracyte Stock Surges 117% in a Year: What's Driving the Rally?
zacks.com
Veracyte Stock Surges 117% in a Year: What's Driving the Rally?

VCYT's 117% stock surge is driven by durable growth plans, Afirma demand, TrueMRD progress, internat

What to Know About This $197,000 Veracyte Insider Sale After a 120% Stock Rally
fool.com
What to Know About This $197,000 Veracyte Insider Sale After a 120% Stock Rally

A director of Veracyte reported selling 3,729 shares for a transaction value of approximately $197K

Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term
zacks.com
Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

Cathie Wood Sells Robinhood Stock, Doubles Down On This George Soros-Backed AI Stock
benzinga.com
Cathie Wood Sells Robinhood Stock, Doubles Down On This George Soros-Backed AI Stock

On Wednesday, June 10, 2026, Ark Invest sold $7.8M in Robinhood shares Wednesday while adding 141,50

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Davita, Bloomin' Brands, Compass And Other Big Stocks Moving Higher On Wednesday
benzinga.com
Davita, Bloomin' Brands, Compass And Other Big Stocks Moving Higher On Wednesday

Dow Jones up 500 points, DaVita Inc (DVA) shares rise after better-than-expected earnings and raised

Earnings Scheduled For May 5, 2026
benzinga.com
Earnings Scheduled For May 5, 2026

Earnings Scheduled For February 25, 2026
benzinga.com
Earnings Scheduled For February 25, 2026

Meihua International Medical Technologies, Fly-E Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com
Meihua International Medical Technologies, Fly-E Group And Other Big Stocks Moving Lower In Monday's

Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday
benzinga.com
Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Mov

Earnings Scheduled For November 4, 2025
benzinga.com
Earnings Scheduled For November 4, 2025

benzinga.com
Earnings Scheduled For August 6, 2025

benzinga.com
Earnings Scheduled For May 7, 2025

benzinga.com
Earnings Scheduled For February 24, 2025

benzinga.com
Shopify Posts Upbeat Earnings, Joins Axon Enterprise, Aspen Technology, Illumina, Global Payments An

benzinga.com
Earnings Scheduled For February 22, 2024

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings

benzinga.com
Earnings Scheduled For November 7, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

benzinga.com
Earnings Scheduled For August 8, 2023

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea

benzinga.com
Earnings Scheduled For May 4, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a

benzinga.com
Earnings Scheduled For February 22, 2023

Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023

benzinga.com
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday

Gainers

benzinga.com
Earnings Scheduled For November 2, 2022

Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for i

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 807 companies reached new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During Thursday, 351 stocks hit new 52-week lows.

benzinga.com
Earnings Scheduled For May 3, 2022

  Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to repo

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During Thursday, 849 stocks hit new 52-week lows.

benzinga.com
Earnings Scheduled For February 28, 2022

  Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to repo

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  During Friday's session, 445 companies made new 52-week lows.